Cardiovascular Advances in Research and Opportunities Legacy Act
This act addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.
The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly.
The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.
[117th Congress Public Law 244]
[From the U.S. Government Publishing Office]
[[Page 2339]]
CARDIOVASCULAR ADVANCES IN RESEARCH AND OPPORTUNITIES LEGACY ACT
[[Page 136 STAT. 2340]]
Public Law 117-244
117th Congress
An Act
To amend title IV of the Public Health Service Act to direct the
Director of the National Institutes of Health, in consultation with the
Director of the National Heart, Lung, and Blood Institute, to establish
a program under which the Director of the National Institutes of Health
shall support or conduct research on valvular heart disease, and for
other purposes. <<NOTE: Dec. 20, 2022 - [H.R. 1193]>>
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled, <<NOTE: Cardiovascular
Advances in Research and Opportunities Legacy Act. 42 USC 201 note.>>
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Cardiovascular Advances in Research
and Opportunities Legacy Act''.
SEC. 2. <<NOTE: 42 USC 285b-9.>> HHS VALVULAR HEART DISEASE
ACTIVITIES.
(a) In General.--The Secretary of Health and Human Services
(referred to in this section as the ``Secretary'') shall, as
appropriate, continue activities related to research, education, and
awareness of valvular heart diseases.
(b) NIH Research Related to Valvular Heart Diseases.--
(1) In general.--The Director of the National Institutes of
Health, in consultation with the Director of the National Heart,
Lung, and Blood Institute, may support or conduct research
regarding valvular heart diseases.
(2) Support further research.--In order to improve
information on, and understanding of, causation and risk factors
for valvular heart diseases, research conducted or supported
under this subsection for such diseases may include the
following:
(A) <<NOTE: Data.>> Use of advanced technological
imaging and other relevant methods to generate data
related to valvular heart diseases.
(B) <<NOTE: Assessments.>> Assessing potential risk
factors for sudden cardiac arrest or sudden cardiac
death from valvular heart diseases.
(C) Other activities, as appropriate, in order to
improve the availability of information on, and advance
research related to, valvular heart diseases.
(3) <<NOTE: Deadline.>> Mitral valve prolapse workshop.--
Not later than 2 years after the date of enactment of this Act,
the Director of the National Heart, Lung, and Blood Institute
shall, as appropriate, convene a workshop composed of subject
matter experts and stakeholders to identify research needs and
opportunities to develop recommendations for the identification
and treatment of individuals with mitral valve prolapse,
[[Page 136 STAT. 2341]]
including such individuals who may be at risk for sudden cardiac
arrest or sudden cardiac death.
(c) Prevention Activities to Improve Awareness of Sudden Cardiac
Death as a Result of Valvular Heart Diseases.--
(1) <<NOTE: Grants. Contracts.>> In general.--The Secretary
may carry out activities to increase education and awareness of
valvular heart diseases in order to reduce the incidence of
sudden cardiac death caused by such diseases. The Secretary
may--
(A) award grants or contracts to public or nonprofit
private entities to carry out activities under this
subsection; and
(B) directly, or through grants or contracts,
provide technical assistance with respect to such
activities.
(2) Certain activities.--Upon availability of applicable
data, projects carried out under paragraph (1) may include--
(A) continuing activities at the Centers for Disease
Control and Prevention related to valvular heart
diseases;
(B) improving the awareness of the public concerning
any risk factors for, the symptoms of, and the public
health impact of, valvular heart diseases; and
(C) enhancing public health data collection and
improving the quality of such data, as appropriate,
regarding cardiac arrests, including cardiac arrests
that occur outside of the hospital.
(3) Grant prioritization.--The Secretary may, in awarding
grants or entering into contracts pursuant to paragraph (1),
give priority to entities seeking to carry out projects for
populations most impacted by valvular heart diseases.
(4) Coordination of activities.--The Secretary shall, as
appropriate, ensure that activities under this section are
coordinated with other agencies and offices of the Department of
Health and Human Services that carry out activities regarding
valvular heart diseases.
(5) Best practices.--The Secretary shall, as applicable and
appropriate, identify and disseminate best practices for
relevant health care providers related to valvular heart
diseases.
[[Page 136 STAT. 2342]]
(d) <<NOTE: Time period.>> Authorization of Appropriations.--For
purposes of carrying out this section, there are authorized to be
appropriated $28,000,000 for each of fiscal years 2023 through 2027.
Approved December 20, 2022.
LEGISLATIVE HISTORY--H.R. 1193:
---------------------------------------------------------------------------
HOUSE REPORTS: No. 117-212 (Comm. on Energy and Commerce).
CONGRESSIONAL RECORD:
Vol. 167 (2021):
Dec. 8, considered and passed House.
Vol. 168 (2022):
Dec. 1, considered and passed
Senate, amended.
Dec. 5, House concurred in Senate
amendment.
<all>
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Measure laid before Senate by unanimous consent. (consideration: CR S6946-6947)
The committee substitute withdrawn by Unanimous Consent.
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S6947)
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S6947)
Message on Senate action sent to the House.
Mr. Pallone moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H8755-8756)
Enacted as Public Law 117-244
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line
DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1193.
Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote.
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H8755)
Motion to reconsider laid on the table Agreed to without objection.
Presented to President.
Presented to President.
Signed by President.
Signed by President.
Became Public Law No: 117-244.
Became Public Law No: 117-244.